Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Catalpol as a Component of Rehmannia glutinosa Protects Spinal Cord Injury by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis

Catalpol as a Component of Rehmannia glutinosa Protects Spinal Cord Injury by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis

Frontiers in Pharmacology, 2022 · DOI: 10.3389/fphar.2022.860757 · Published: July 8, 2022

Spinal Cord InjuryPharmacologyNeurology

Simple Explanation

Spinal cord injury (SCI) often leads to motor and sensory dysfunction of the lower limbs. Rehmannia glutinosa, a traditional Chinese medicine, is used in neurodegenerative diseases. Catalpol (CAT), an extract of Rehmannia glutinosa, has antioxidant, antiapoptotic, and neuroprotective effects and can treat SCI by inhibiting ER stress-mediated neuronal apoptosis.

Study Duration
30 days
Participants
Rats with induced spinal cord injury
Evidence Level
Not specified

Key Findings

  • 1
    CAT has a restorative effect on the lower limb motor function of rats with SCI.
  • 2
    CAT inhibits apoptosis and protects neurons by reducing endoplasmic reticulum (ER) stress.
  • 3
    CAT reduces ER stress by inhibiting CHOP and GRP78 expression, thus reducing apoptosis and protecting neurons through the Caspase3/Bax/Bcl-2 pathway.

Research Summary

This study investigates the neuroprotective effects of catalpol (CAT) on spinal cord injury (SCI) in rats. The research demonstrates that CAT promotes functional recovery in SCI rats by inhibiting ER stress-mediated neuronal apoptosis. The findings suggest that CAT has the potential to be a clinical drug for the treatment of SCI.

Practical Implications

Potential Clinical Drug

Catalpol could be developed as a therapeutic agent for spinal cord injury.

Targeting ER Stress

Treatments aimed at reducing endoplasmic reticulum stress may improve outcomes after SCI.

TCM Validation

This study supports the use of Rehmannia glutinosa, a traditional Chinese medicine, in treating neurodegenerative conditions and SCI.

Study Limitations

  • 1
    The study was conducted on rats, and results may not directly translate to humans.
  • 2
    The specific mechanisms of CAT action may require further elucidation.
  • 3
    The long-term effects of CAT treatment were not investigated.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury